WHO vaccine-preventable diseases: monitoring system. 2014 global summary

Last updated 15-Jul-2014 (Data received as of 8-Jul-2014)
Next overall update Fall 2014
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 4101 Infant (under 12 months) mortality rate: 632
GDP / capita (US$): 9131 Child (under 5 years) mortality rate: 1142

Population data in thousands3

  2013  2012  2011  2010  2009  2000  1990  1980 
Total population 17'831  17'157  16'511  15'894  15'303  10'990  7'754  5'834 
Births 890  858  828  799  772  585  429  322 
Surviving infants 843  812  782  753  725  532  370  279 
Pop. less than 5 years 3'695  3'557  3'420  3'282  3'160  2'261  1'544  1'161 
Pop. less than 15 years 8'932  8'586  8'249  7'919  7'611  5'268  3'703  2'776 
Female 15-49 years 3'698  3'561  3'434  3'315  3'196  2'378  1'759  1'330 

Number of reported case

(Click for retrospective incidence data for Niger (the))
Diphtheria 73  12  102  34 
Japanese encephalitis
Measles 1'224  272  771  372  801  21'319  20'463  36'811 
Mumps
Pertussis 884  983  30  1'354  5'585  3'102  8'320 
Polio* 15  33  32  311 
Rubella 77  19  11 
Rubella (CRS)
Tetanus (neonatal) 11  13  14  55  39 
Tetanus (total) 71  75  131  146  157  286  220  346 
Yellow fever 20 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Niger (the))
Vaccine year result method % card seen                                                
BCG 2011  84  DHS/MICS   65  59  99*  71  95  96  35  82 
DTP1 2011  86  DHS/MICS   65  98  99*  99*  99  100  35 
DTP3 2011  68  DHS/MICS   65  92  96  97  92  93  25  35 
HepB_BD         
HepB3          92  96  97  92  93 
Hib3          92  96  97  92  93 
JapEnc         
MCV 2011  69  DHS/MICS   65  92  91  94  89  87  27  38 
MCV2         
PCV1         
PCV3         
Pol3 2011  75  DHS/MICS   65  80  95  61  92  88  23  35 
Rota1         
Rota_last         
Rubella1         
TT2plus 2011  50  DHS/MICS   65  89  83  93  85  81  31  11 
PAB         
VAD1          50  58  63  53  45 
YFV          88  90  69  82  85  10 
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Niger (the))
BCG 49  97  61  85  86  50  50 
DTP1 85  85  86  83  81  46  46 
DTP3 70  74  75  70  71  34  22 
HepB3 70  74  75  70  71 
HepB_BD
Hib3 70  74  75  70  71 
MCV 67  66  69  67  69  37  25 
MCV2
PAB 81  84  84  84  84  63  17 
PCV3
Pol3 63  78  44  75  71  41  22 
Rota_last
YFV 70  72  51  64  67  10 

Number of districts in the country 42  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 60
From 80 to 89% 31
From 50 to 79% 10
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2013 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 6, 10, 14 weeks; Yes
HPV 11 years; +3, +7 months; No From March 2014
Measles 9, 16 months; Yes
OPV birth; 6, 10, 14 weeks; Yes
Pneumo_conj 6, 10, 14 weeks; Yes From July 2014
Rotavirus 6, 10 weeks; Yes From July 2014
TT 1st contact or pregnancy, +4 weeks; +6 months; +1, +1 years; Yes
VitaminA 6, 11 months; Yes
YF 9 months; Yes

Immunizaton indicators

Indicator Expected answer 2013  2012  2011  2010  2009  2008  2007 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2011 - 2015  2011-2015  2011 - 2015  2011 - 2015  2007 - 2010  2007 - 2010  2007 - 2010 
Nº of districts with microplans that include activities to raise immunization coverage number 42  42  42  42  42  42  42 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes    No  No       

System performance

Total Nº districts in country number 42  42  42  42  42  42  42 
Nº districts with DTP3 coverage >=80% number 38  41  38  38  40  36  13 
% of districts with DTP3 coverage >=80% From 0 to 100% 90  98  90  90  95  86  31 
Nº districts with measles (MCV1) coverage >=95% number 19  18  22  11  12   
% of districts with MCV1 coverage >=95% From 0 to 100% 45  43  52  26  29  21   

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  No  No       
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Estimated percentage of routine vaccines funded by Government From 0 to 100%     14  14  29  72 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.